Kevin Ness
Directeur/Membre du Conseil chez Foresite Life Sciences Corp.
Fortune : 2 M $ au 30/04/2024
Profil
Kevin D.
Ness was the founder of QuantaLife, Inc. (founded in 2008) and 10X Genomics, Inc. (founded in 2012) where he held the titles of Director & VP-Product Development and Chief Operating & Technology Officer respectively.
He currently holds a Director position at Foresite Life Sciences Corp.
Kevin's former position was as President, Chief Executive Officer & Director at Inscripta, Inc. Kevin's education includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of California, Santa Barbara.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/02/2024 | 3 060 000 ( 4,48% ) | 2 M $ | 30/04/2024 |
Postes actifs de Kevin Ness
| Sociétés | Poste | Début |
|---|---|---|
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kevin Ness
| Sociétés | Poste | Fin |
|---|---|---|
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Directeur Général | 27/10/2020 |
| 10X GENOMICS, INC. | Fondateur | 01/09/2016 |
QuantaLife, Inc.
 QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Fondateur | 01/09/2012 |
Formation de Kevin Ness
| Stanford University | Doctorate Degree |
| University of California, Santa Barbara | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 10X GENOMICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
QuantaLife, Inc.
QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Commercial Services |
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Finance |
